In particular, for breast cancer, many studies have investigated the expression of Ki-67 and suggested it as a prognostic and predictive marker (27, 28); its decreased expression has been associated with the reduction of tumor growth and efficacy of anticancer treatment (26, 28), which was already seen in our experiments. This evidence concerns the gene MKI67 and breast cancer.